Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ruchir Trivedi"'
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291649 (2023)
Bone disease is highly prevalent in patients with chronic kidney disease (CKD), leading to an increased risk of bone fractures. This is due in part to metabolic acid-induced bone dissolution. Bisphosphonates (BPPs) are a potential treatment for inhib
Externí odkaz:
https://doaj.org/article/7f453ff2139445ee860acf6fe013d548
Autor:
Ruchir Trivedi, George Fares, Victoria Barany Nunez, Ryan Campbell, Megyn Clement, Joseph Burleson, Jonathan Himmelfarb, Effie Ioannidou
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Given the importance of inflammation as a predictor of poor outcomes in End Stage Renal Disease (ESRD), reductions in inflammatory biomarkers have been proposed as a critical target in this population. This study targets chronic p
Externí odkaz:
https://doaj.org/article/087daed2d1f043fdaed390bbf3f1585c
Publikováno v:
Burket's Oral Medicine. :579-626
Publikováno v:
Cureus.
Publikováno v:
Therapeutic Apheresis and Dialysis. 24:599-601
Autor:
Effie Ioannidou, Jonathan Himmelfarb, Ryan Campbell, Megyn Clement, Ruchir Trivedi, Victoria Barany Nunez, Joseph A. Burleson, George Fares
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-10 (2018)
Trials
Trials
Background Given the importance of inflammation as a predictor of poor outcomes in End Stage Renal Disease (ESRD), reductions in inflammatory biomarkers have been proposed as a critical target in this population. This study targets chronic periodonti
Autor:
Marissa C. Salvo, Ruchir Trivedi
Publikováno v:
The Medical clinics of North America. 100(5)
Dietary supplements are commonly used by patients as part of their medical care plan. Often clinicians may not be aware of their use, because patients do not always consider these to be medications. All clinicians need to continually ask patients abo
Publikováno v:
The American Journal of Medicine. 130:e449-e450
Publikováno v:
Connecticut medicine. 77(8)
Thyrotoxic Hypokalemic Periodic Paralysis (THPP) is a rare complication of thyrotoxicosis and can sometimes be fatal. It needs early recognition for proper management and prevention of recurrences. Here we describe two cases presenting with acute ons
Publikováno v:
American Journal of Kidney Diseases. 57:B97